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Olmsted*County,*Minnesota,*USA* ! ! !
Sedlack!et#al.#(1980)! 1935Y1954! 1.9! !1955Y1964! 4.0! !1965Y1975! 6.6! !1976! ! 105.7!Loftus!et#al.#(1998)! 1991! ! 133!
Loftus!et#al.#(2007)!
1940Y1949! 2.3! !1950Y1959! 2.6! !1960Y1969! 6.5! !1970Y1979! 7.9! !1980Y1989! 6.8! !1990Y2000! 7.9! !2000! ! 174!
Manitoba,*Canada* ! ! !Bernstein!et#al.#(1999)! 1989Y1994! 14.6! !1994! ! 198.5!Blanchard!et#al.#(2001)! 1987Y1996! 15.6! !Bernstein!et#al.#(2006)# 1998Y2000! 15.4! 271.4!
Copenhagen*County,*Denmark! ! ! !Binder!et#al.#(1982)# 1970Y1978! 2.7! !1978! ! 34!Munkholm!et#al.#(1992)! 1979Y1987! 4.1! !1987! ! 50.4!Vind!et#al.#(2006)! 2003Y2005! 8.6! !
Stockholm*County,*Sweden*
Lapidus!et#al.#(1997)!
1955Y1959! 1.4! !1960Y1964! 2.2! !1965Y1969! 3.7! !1970Y1974! 4.8! !1975Y1979! 4.4! !1980Y1984! 4.5! !1985Y1989! 4.9! !Lapidus!et#al.#(2006)! 1990Y2001! 8.3! 213!
Northern*France*(EPIMAD*registry)!
Whole!cohort!(Chouraki!et!al.,!2011)! 1988Y1990! 5.2! !1997Y1999! 7.1! !2006Y2007! 6.7! !Subgroup!analysis!of!the!10Y19!age!group!!(Chouraki!et!al.,!2011)! 1988Y1990! 6.5! !2006Y2007! 11.1! !














































































Corticosteroids* ! ! !
Prednisolone!Methylprednisolone!Budesonide! 51Y64%!(Benchimol!et!al.,!2008;!Greenberg!et!al.,!1994)! No!role.!
Steroid!sideYeffects,!including!“moon!face”,!“buffalo!hump”,!glucose!intolerance,!myopathy,!osteoporosis,!etc.!
Thiopurines* ! ! !Azathioprine!6Ymercaptopurine! No!role.!(Chande!et!al.,!2013).! 51Y71%!(Prefontaine!et!al.,!2009)! Bone!marrow!suppression,!pancreatitis,!lymphoma!(rare)!









AntiSα4*integrin* ! ! !
Natalizumab! Remission:!26%!Response:!48%!(Targan!et!al.,!2007)! Remission:!44%!Response:!61%!(Sandborn!et!al.,!2005)!
Progressive!multifocal!leukoencephalopathy!(Van!Assche!et!al.,!2005)!
AntiSα4*β7*heterodimer* ! ! !Vedolizumab! Remission:!14.5%!Response:!31.4%!(Sandborn!et!al.,!2013)! Remission:!36Y39%!Response:!43Y45%!(Sandborn!et!al.,!2013)! Infections!












































































Target* Name* Class* Comments*
α4*integrin* AJM300! Small!molecule! Efficacy!in!phase!II!study!in!CD.!!Published!in!abstract!form!only.!!(Takazoe!et!al.,!2009b)!
HGH* Somatotropin! Recombinant!hormone! Efficacy!in!adult!phase!II!study!(Slonim!et!al.,!2000).!!No!additional!efficacy!when!given!with!steroids!in!paediatric!CD!(Denson!et!al.,!2010).!
ILS6R*
Tocilizumab!(Atlizumab/MRA)! Humanised!mAb! Efficacy!in!phase!II!study!(Ito!et!al.,!2004).!
ILS10* rhuILY10! Recombinant!cytokine! Phase!IIa!clinical!trials,!testing!SC!and!bacteriallyYdelivered!ILY10.!!(Braat!et!al.,!2006;!Fedorak!et!al.,!2000;!Schreiber!et!al.,!2000).!!Other!companies!have!ILY10Ybased!molecules!in!their!pipelines.!









TNF* Golimumab! Fully!human!mAb! Efficacy!shown!in!phase!III!study!in!UC!(Löwenberg!and!D'Haens,!2013).!
TNF* Thalidomide! IMiD! Positive!results!in!phase!II!clinical!trials!(Ehrenpreis!et!al.,!1999;!Vasiliauskas!et!al.,!1999).!
TNF* Semapimod! MAPK!inhibitor! Phase!I!(Hommes!et!al.,!2002).!
Microbiome* Rifaximin! Antibiotic! Phase!II!(Prantera!et!al.,!2012).!!!! !
! 61!
Table*8.4:**Investigational*therapies*for*Crohn’s*disease*that*have*failed*in*clinical*trials.*!
Target* Name* Class* Comments*
CCR9*
Vercirnon!(CCXY282B)! Small!molecule! Successful!phase!II!trial!(Keshav!et!al.,!2013).!!Phase!III!terminated!early.!
CD3* Visilizumab! Humanised!mAb! Cytokine!release!syndrome!and!liver!injury!in!phase!IIa!studies!(Baumgart!et!al.,!2009).!
CTLAS4* Abatacept! Humanised!mAb! Phase!II!(Sandborn!et!al.,!2012a).!
ICAMS1*
Alicaforsen!(ISIS!2302)! Antisense!oligonucleotide! IV!administration!failed!to!induce!remission!in!moderateYtoYsevere!CD!(Yacyshyn!et!al.,!2007).!!Topical!administration!shows!some!promise!in!UC.!
IFNSγ * Fontolizumab! Humanised!mAb! Failed!to!meet!primary!endpoint!of!efficacy!at!day!29!in!phase!II!trial.!!Decreased!CRP!in!treatment!group!(Reinisch!et!al.,!2010).!!





ILS17A* Secukinumab! Humanised!mAb! Phase!III!(Hueber!et!al.,!2012).!
GMSCSF* Sargramostim! Recombinant!cytokine! Phase!II!(Korzenik!et!al.,!2005;!Takazoe!et!al.,!2009a).!
TNF* CDP517! Humanised!mAb! Phase!III.!!SubYgroup!analysis!suggested!efficacy!in!subjects!with!CRP>10mg/L!(Sandborn!et!al.,!2004).!
TNF** Lenalidomide! IMiD! Phase!II;!moderate!CD!(Mansfield!et!al.,!2007).!
TNF*
Doramapimod!(BIRB!793)! MAPK!inhibitor! Phase!II!(Schreiber!et!al.,!2006).!
TNF*p55* Onercept! Soluble!p55R! Phase!III!(Rutgeerts!et!al.,!2006).!


















































































































































































































































































































































Study*name/PI* Leading*Sites* ClinicalTrials.gov*identifier* Context*
Baron/Beguin! University!Hospital!of!Liege! NCT01903473! Treatment!of!chronic!GvHD.!
Bluestone/Feng! University!of!California,!San!Francisco! NCT02188719! AntigenYspecific!expanded!Tregs.!!Reduction!in!acute!or!chronic!rejection!following!liver!transplantation.!
Bluestone/Herold! University!of!California,!San!Francisco! NCT01210664! Polyclonally!expanded!Tregs.!!Safety!in!paediatric!T1DM.!
Brunstein/Blazar! U!Minnesota!Masonic!Cancer!Centre,!Minneapolis! NCT02118311! Phase!II!clinical!trial!of!polyclonally!expanded!UCB!Tregs.!!Prevention!of!acute!GvHD!with!double!UCB!HSCT.!
Bykovskaia/Kaabak! Russian!State!Medical!University,!Moscow! NCT01446484! Polyclonally!expanded!Tregs.!Prevention!of!renal!transplant!rejection!in!children.!
The!ONE!Study!(ONETreg1)! King’s!College!London!Oxford!University! NCT02129881! Polyclonally!expanded!Tregs.!Prevention!of!renal!transplant!rejection.!
The!“ThRIL”!study!SanchezYFueyo! King’s!College!London! NCT02166177! AntigenYspecific!expanded!Tregs.!!Reduction!in!immunosuppressive!burden!following!liver!transplantation.!






































































































































Specificity* Fluorochrome* Clone*CD3*! APCYH7! SK7!CD4*! V500! RPAYT4!CD25*! PE! 2A3!CD127*! Brilliant!Violet™!650! A019D5!CD45RA*! AlexaFluor®!700! HI100!CD45RO*! Brilliant!Violet™!570! UCHL1!CD49d!(α4!integrin)! PerCPYCy5.5! 9F10!
β7!integrin! FITC! FIB504!CD62L! Pacific!Blue! DREGY56!CD161! Brilliant!Violet™!605! HP3G10!Live/Dead!Blue! DAPI!(UV!450/50)! !
Additional*Antibodies*for*Panel*1*
Specificity* Fluorochrome* Clone*CCR7!(CD197)! PEYCF594! 150503!CCR6!(CD196)! APC! G034E3!CXCR3!(CD183)! PEYCy7! IC6/CXCR3!
Additional*Antibodies*for*Panel*2*































































































Figure* 10.3* (continued):* Gating* strategy* to* assess* TregSmediated* suppression* of* CD69* and*
CD154*expression*in*Tcons.**
(E*&*F)!To!determine!if!the!exclusion!of!activated!CD4+CD25int!Tcons!affected!the!results!of!the!assay,!Tregs!were!labelled!with!CTV!and!the!assay!repeated.! !After!7h,!TregYmediated!suppression!of!CD69!and! CD154! was! analysed! in! all! (CTVYnegative)! Tcons! (E* top* panels)! and! CD25Y! Tcons! (E* bottom!























(A)*Representative! example! of! a! 96Yhour! CFSE! dilution! assay,! gated! on! live! Tcons,! cultured! alone!(left)!or!at!a!1:1!Tcon:Treg!ratio!(right).! !Gates!illustrating!each!division!are!shown.! !The!number!of!nonYproliferated!precursors!(as!a!percent!of!precursors!of!all!divided!cells)!is!highlighted.!!!
(BSC)! !Suppression!of!proliferation!at!96!hours!at!increasing!Tcon:Treg!ratios!from!a!representative!experiment!(B)!and!pooled!data!from!10!independent!experiments!(C).!!(DSE)**Agreement!between!suppression! of! CD69! and! CD154! expression! at! 7h! and! inhibition! of! proliferation! at! 96h.! ! BlandYAltman!plots!showing!the!limits!of!agreement!(mean!and!95%!confidence!interval)!between!paired!values!for!freshly!isolated!TregYmediated!suppression!of!Tcon!proliferation!at!96h!(“gold!standard”)!and!TregYmediated!suppression!of!CD69!(D)!or!CD154!(E)!expression!(“comparator”!tests)!at!7h.!!(FS


















PPV* NPV* LR+* LRS*
CD69* * * * * * *!Lower!quartile:!>9.9%! 93%!(68Y100%)! 40%!(20Y64%)! 61%! 86%! 1.6! 0.2!!Median:!>28.6%! 67%!(42Y85%)! 67%!(42Y85%)! 67%! 67%! 2.0! 0.5!!Upper!quartile:!>39.6%! 40%!(20Y64%)! 93%!(68Y100%)! 86%! 61%! 6.0! 0.6!!Minimum!cost:!37.4%! 53%!(30Y75%)! 93%!(68Y100%)! 89%! 67%! 8.0! 0.5!
































Figure* 10.7* (continued):* Suppression* at* 7* hours* by* in# vitro* expanded* Tregs* predicts*
suppression*of*proliferation*at*96*hours.*











PPV* NPV* LR+* LRS*
CD69* * * * * * *!Lower!quartile:!>15.5%! 94%!(69Y100%)! 44%!(23Y67%)! 63%! 88%! 1.7! 0.1!!Median:!>24.1%! 63%!(39Y82%)! 69%!(44Y86%)! 6%7! 65%! 2.0! 0.5!!Upper!quartile:!>40.1%! 25%!(10Y50%)! 81%!(56Y94%)! 57%! 52%! 1.3! 0.8!!Minimum!cost:!43.8%! 13%!(3Y38%)! 94%!(69Y100%)! 67%! 52%! 2.0! 0.9!












vitro!expanded!TregYmediated!suppression!of!target!cells.!!!! ROC!curves!constructed!to!explore!the!usefulness!of!marker!suppression!at!7!hours!as!a!“diagnostic!test”!for!median!values!of!ILY2!suppression!at!96!hours!showed!excellent!discrimination!for!both!freshly!isolated!Tregs!(AUC!of!0.92,!95%!CI,!0.87Y0.97,!p<0.0001;!and!AUC!of!0.98,!0.85Y1.0;!p<0.0.0001!for!CD69!and!CD154!suppression,!respectively)!and!in#vitro!expanded!Tregs!(AUC!of!0.79,!95%!CI,!0.64Y0.95;!p<0.0001;!and!AUC!of!0.97,!0.84Y0.99;!p<0.0001;!for!CD69!and!CD154!suppression,!respectively).!!ROC!curve!analysis!also!determined!that!freshly!isolated!TregYmediated!suppression!of!CD69!and!CD154!on!Tcons!was!not!useful!in!discriminating!median!values!of!IFNYγ!suppression!at!96!hours!(AUC!of!0.74,!95%!CI,!0.46Y1;!p=not!significant;!and!AUC!of!0.71,!0.44Y0.99;!p=not!significant;!for!CD69!and!CD154!suppression,!respectively).!!Because!in#vitro!expanded!Tregs!did!not!suppress!IFNYγ!expression!in!coYculture!supernatants,!this!analysis!was!not!performed!for!in#vitro!expanded!Tregs.!! Taken!together,!these!data!suggest!that!suppression!of!ILY2!at!96!hours!can!be!predicted!by!suppression!of!CD69!and!CD154!at!7!hours!for!both!freshly!isolated!and!in#vitro#expanded!Tregs.!! !
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Figure*10.8:*Suppression*of*cytokine*production*at*96*hours*is*predicable*at*7*hours.*
















































































































! MACS*alone*(n=10)* MACS*+*FACS*(n=13)* p*Female!sex! 5! (50%)! 6! (46.1%)! 0.85!Age![years]!(median,!IQR)! 40.9! (30.3Y48.6)! 40.7! (38.1Y49.0)! 0.56!Age!at!diagnosis![years]!(median,!IQR)! 28.2! (16.9Y37.9)! 20.7! (17.6Y36.8)! 0.88!Disease!duration![years]!(median,!IQR)! 8.5! (4.9Y15.6)! 17.2! (4.9Y21.7)! 0.44!
Age#at#Diagnosis*# ! ! ! ! !Diagnosis!<16!y.o.!(A1)! 2! (20%)! 2! (15.4%)! 0.10!Diagnosis!17Y40!y.o.!(A2)! 6! (60%)! 9! (69.2%)!Diagnosis!>40!y.o.!(A3)! 2! (20%)! 2! (15.4%)!
Location*# ! ! ! ! !IlealYonly!(L1)! 2! (20%)! 1! (7.7%)! 0.63!Colonic!only!(L2)! 2! (20%)! 4! (30.8%)!IleoYcolonic!(L3)! 6! (60%)! 8! (61.5%)!Concomitant!upper!GI!disease!(L4)! 0! 0! 2! (15.4%)! !Perianal!disease!(p)! 2! (20%)! 2! (15.4%)! !
Disease#Behaviour*# ! ! ! ! !Inflammatory!(B1)! 4! (40%)! 9! (69.2%)! 0.32!Stricturing!(B2)! 2! (20%)! 2! (15.4%)!Penetrating!(B3)! 4! (40%)! 2! (15.4%)!
Disease#Activity# ! ! ! ! !Harvey!Bradshaw!Index!(median,!range)! 0.5! (0Y6)! 0! (0Y7)! 0.66!Active!disease!HBI!>=5! 1! (10%)! 4! (30.8%)! 0.31!





































































(A)! IFNYγ,! ILY4,! ILY17!and!TNF!secretion!by!day!24! in#vitro#expanded!Tregs,!detected!by!cytometric!bead!array!(FACS)!on!24h!culture!supernatants.! !(B)! ILY17!detected!by!ELISA! from!5Yday!culture!supernatants! of! day! 24! in# vitro# expanded! Tregs! cultured! in! the! absence! of! rapamycin! but! with!supplemental!ILY2!alone,!a!cocktail!of!ILY2,!ILY1,!ILY6!and!TGFYβ!(Mix!A)!or!a!cocktail!of!ILY2,!ILY21,!ILY23!and!TGFYβ!(Mix!B).!!Bar!at!median.!!*p<0.05,!**p<0.01,!***p<0.001.!!
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Figure*11.8*(continued):*In#vitro#expanded*Treg*plasticity.!
(C)!Expression!of!RORC,!AHR! and! IL17A! in!day!24! in#vitro#expanded!CD45RA+!and!CD45RAY!Tregs,!detected!by!rtPCR.! !(D)!CD4+CD25hiCD127lo!cell!surface!phenotype!detected!by!FACS! in!day!24! in#


























receptors* and* home* to* inflamed* human* LP* in* a* C.BS17* SCID* mouse* human* intestinal*
xenograft*model.*
(C)! Design! of! the! xenograft! mouse! experiment.! ! Foetal! small! intestine! was! implanted!subcutaneously! on! the! dorsum! of! a! C.BY17! SCID!mouse! and! allowed! to!mature! in! situ! for! 12Y16!weeks.!!Following!preYtreatment!with!antiYasialo!GM1!and!rhILY2!(Tresoldi!et!al.,!2011),!day!24!in!vitro! expanded! CD45RA+! Tregs! were! administered! IV.! ! Graft! inflammation! was! induced! by!intraluminal!injection!with!EPEC.!!The!contralateral!graft!was!injected!with!PBS!and!used!as!a!nonYinflamed!control.!!Homing!was!assessed!24h!later.!!(D)!Left!panel:!Mature!xenografts!(circled)!are!visible!subcutaneously!on!the!dorsum!of!the!mouse.!!Right!panel:!Dorsal!skin!has!been!removed!in!an!anesthetized!mouse!to!reveal!the!mucusYfilled!xenograft!in!situ!(right!panel).!!Scale!bars=1cm.!
! 233!
Figure*11.9*(continued):*In#vitro*expanded*CD45RA+*Tregs*express*gut*and*lymphoid*homing*
receptors* and* home* to* inflamed* human* LP* in* a* C.BS17* SCID* mouse* human* intestinal*
xenograft*model.!




receptors* and* home* to* inflamed* human* LP* in* a* C.BS17* SCID* mouse* human* intestinal*
xenograft*model.*
(G)! ! FACS! plots! showing! live! human! CD45+CD3+CD4+! events! in! single! cell! suspensions! prepared!from!murine!!spleen,!nonYinflamed!and!inflamed!xenografts!(XG),!24h!after!IV!PBS!(left!panels)!or!adoptive! transfer! of! Tregs! (right! panels).! ! The! gating! strategy! is! illustrated! in! Figure! 11.9! F.! ! The!absolute!number!of!CD3+CD4+!events!in!the!xenograft!human!CD45+!gates!are!highlighted.!!!
















(A)!Fresh! ileal!resection!specimen!opened! longitudinally! to!show!ileal!stricture!(marked!“S”)!and!proximal!inflamed,!haemorrhagic!mucosa!with!deep!ulceration!(arrows).!!Scale!bar:!2cm.!!!







(D)!Representative!FACS!plots!gated!on!live!LP!CD3+!events!showing!CD154!expression!on!LP!Tcons!cultured!alone!(at!a!1:0!LPMC:Treg!ratio,!top!left!panel)!or!with!Tregs!at!a!1:1!LPMC:Treg!ratio!(bottom!left!panel).! !Pooled!data! showing!TregYmediated!suppression!of!CD154!expression! in! live!LP!CD3+!cells! (right! panel,! n=5).! ! (E)! Representative! FACS! plots! gated! on! live! CD3+! events,! showing!proliferation!of!MLN!Tcons!cultured!alone!(at!a!1:0!MLNMC:Treg!ratio,!top!left!panel)!or!with!Tregs!at!a!1:1!MLNMC:Treg!ratio!(bottom!left!panel).!!Pooled!data!showing!TregYmediated!suppression!of!MLN!CD3+!proliferation!(right!panel,!n=5).!!Box!and!whisker!plot!shows!median,!IQR!and!range.!!!














































































































































































































1.0!! 4.5!! 6.0!! 8.0!! 10.0!!
A:!!(10,20,30,40,50)%! 28.6! 33.3! 20.3! 6.1! 1.7! 20.3! 59.7! 1.7!
B:!!(5,10,20,30,40)%! 12.4! 27.7! 32.2! 18.1! 9.6! 18.1! 59.9! Y!
C:!!(5,10,15,20,30)%! 12.2! 17.1! 21.8! 23.8! 25.1! 25.1! 48.9! Y!
































1.0!! 4.5!! 6.0!! 8.0!! 10.0!!







1.0* 4.5* 6.0* 8.0* 10.0*
A:!!(10,20,30,40,50)%! 38.5%! 32.0%! 19.7%! 7.9%! 1.9%!
B:!!(5,10,20,30,40)%! 24.8%! 27.0%! 25.5%! 16.3%! 6.4%!
C:!!(5,10,15,20,30)%! 24.1%! 24.5%! 22.4%! 18.1%! 10.9%!
D:*!(10,25,30,35,45)%! 42.0%! 32.9%! 16.2%! 6.8%! 2.1%!! ! ! ! ! !Probability!of!DLT!at!each!dose!level,!in!four!scenarios.!
CRM*design*
Dose*x*106*Tregs/kg*
1.0* 4.5* 6.0* 8.0* 10.0*
A:!!(10,20,30,40,50)%! 11.4%! 24.8%! 32.8%! 21.1%! 9.9%!
B:*!(5,10,20,30,40)%! 5.2%! 8.9%! 24.3%! 32.2%! 29.4%!
C:!!(5,10,15,20,30)%! 5.1%! 6.3%! 9.0%! 19.9%! 59.7%!












(A)! Following! written! informed! consent,! subjects! will! be! screened! at! least! 4! weeks! prior! to! a!planned!infusion!date.! !(B)!PBMCs!will!be!obtained!and!CD4+CD25hiCD127loCD45RA+!Tregs!isolated!and!expanded!in#vitro.!Expanded!cell!lots!will!undergo!quality!control!and!either!be!frozen!for!later!use,! or! infused! fresh.! ! (C)! Subjects! will! receive! baseline! clinical! and! endoscopic! evaluation! (E1)!within!48h!prior!to! infusion,! followed!by!Treg! infusion!at!Guy’s!Hospital’s!clinical!research!facility.!The! first! three!subjects! (or! first! subjects!at!each!dose! level)!will!be!admitted!overnight! following!infusion.!Each!of!these!first!three!subjects!will!receive!cells!sequentially!and!complete!a!5Yweek!per!protocol!observation!period!following!infusion!prior!to!infusing!the!next!subject.**(D)!Subjects!will!be! assessed! frequently! during! the! 12Yweek! followYup! period.! ! A! repeat! endoscopy! will! be!performed! at!week! 5! (E2)! to! assess!mucosal! healing! in! response! to! Treg! therapy.! ! In! addition! to!frequent! !assessment!of!clinical!parameters!(to!determine!safety!and!clinical!response),!extensive!immune! phenotyping!will! be! performed! on! PB! and! LP! samples! to! correlate! changes! in! immune!phenotype!with!clinical!outcome.! !This!will!allow!the!cell!types!and!immune!responses!associated!with!clinical!response!to!be!determined.!!!
! !
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Table*12.4:*Summary*of*required*data*throughout*clinical*trial.*! ! Screening! Days!0,!1*! Week! Week!!(PreYtreatment)! Weeks!1,!2,!3,!5! 8! 12!Medical!history! ✓! ! ✓*! ✓! ✓!Physical!examination! ✓! ! ✓! ✓! ✓!ECG! ✓! ! ✓! ! !Pregnancy!test! ✓! ! ! ! ✓!Colonoscopy! ✓! ! ! ✓! !Radiology!(CT,!MRI,!U/S)! ✓! ! ✓1! ! !Viral!testing:!HIV,!HBV,!HCV! ✓! ! ! ! !Screening!for!TB! ✓! ! ! ! !Stool!for!C&S,!O&P,!C.#difficile! ✓! ! ! ! !Colonoscopy!&!biopsy,!endoscopic!disease!score!(CDEIS)! ✓! ! ✓1! ! !FBC!&!differential! ✓! ! ✓! ✓! ✓!ESR,!CRP,!Calprotectin! ✓! ! ✓! ✓! ✓!Serum!chemistry! ✓! ! ✓! ✓! ✓!Thyroid!function!tests! ✓! ! ! ✓! !Serum!&!biopsy!cytokine!analysis! ✓! ! ✓1! ! ✓!CDAI!calculation! ✓! ! ✓! ✓! ✓!IBDQ!calculation! ! ! ✓2! ✓! ✓!Notes.!*:!History!and!physical!examination!only!at!day!1,!unless!additional!investigations!indicated!clinically.!!1:!Week!5!only.!2.!Weeks!2,!5,!8!and!12!only.!!
12.9.8 Study*endpoints*
! The!safety!of!the!cell!product!will!be!reported!by!enumerating!the!number!of!DLTs,!serious!and!nonYserious!adverse!events!experienced!by!study!subjects!during!the!12Yweek!followYup!period.!!The!MTD!will!be!determined!using!the!dose!escalation!strategy!described!above.!!!
! Efficacy!will!be!determined!at!weeks!5!and!8,!according!to!current!best!practice!(Committee!for!Medicinal!Products!for!Human!Use,!2009;!Desreumaux!et!al.,!2012).!!Clinical!response!will!be!identified!by!a!decrease!in!the!CDAI!of!≥100!points!from!baseline,!while!clinical!remission!will!be!identified!by!an!absolute!CDAI!of!<150!points!!(Best!et!al.,!1976).!!The!severity!of!mucosal!disease!at!
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endoscopy!will!be!evaluated!by!an!independent!observer!using!the!Crohn’s!Disease!Endoscopic!Index!of!Severity!(CDEIS),!a!validated!endoscopic!disease!activity!score!(Ferrante!et!al.,!2013).!!Mucosal!healing!will!be!defined!as!absence!of!ulceration!in!the!colon!and!terminal!ileum,!while!endoscopic!response!will!be!determined!by!a!decrease!in!CDEIS!at!the!second!endoscopy.!
12.9.9 Evaluation*of*the*immune*response*to*autologous*in#vitro*expanded*
Treg*therapy*
! Because!the!investigators!will!have!access!to!PB!and!LP!from!subjects!receiving!autologous!in#vitro!expanded!Treg!therapy,!the!proposed!clinical!trial!will!offer!an!exciting!opportunity!to!evaluate!immune!responses!adoptively!transferred!Tregs!in#vivo!in!humans.!!To!enable!this,!multiYparameter!flow!cytometric!panels!will!be!developed!to!allow!detailed!delineation!of!immune!cell!subsets,!and!the!activation!status!of!immune!cells!within!these!subsets.!!The!cytokine!expression!profile!of!immune!cell!populations!will!be!assessed!by!FACS!and!assessment!of!cytokine!expression!in!24Yhour!cell!culture!supernatants.!!PBMCs,!LPMCs!or!fractionated!cell!populations!will!be!collected!and!stored!in!RNALater,!which!will!allow!subsequent!qPCR!or!microarray!analysis,!in!order!to!define!transcriptional!profiles!associated!with!disease!and!clinical!response.!!In!addition!to!defining!immune!responses!to!Treg!therapy,!this!approach!offers!an!opportunity!to!correlate!immunological!parameters!with!clinical!response!following!treatment,!which!may!provide!and!insight!into!the!immune!pathways!that!are!associated!with!a!clinical!improvement!in!CD.!!!
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! The!anatomic!location!at!which!adoptively!transferred!Tregs!might!exert!their!effect!in!order!to!modulate!immune!responses!in!CD!is!currently!unknown.!!Were!it!possible!to!label!adoptively!transferred!Tregs!in!a!subset!of!recipients,!so!that!their!anatomic!location!could!be!identified!at!various!timeYpoints!(particularly!with!sufficient!resolution!to!discriminate!between!localisation!in!the!intestinal!mucosa!vs.#MLN),!this!question!could!be!addressed!during!this!proposed!clinical!trial.!!In#vivo#tracking!of!Tregs!is!currently!the!subject!intensive!research!within!the!division!(SharifYPaghaleh!et!al.,!2011).!
12.10 Overcoming*clinical*and*economic*barriers*to*incorporating*
autologous*Treg*cell*therapy*within*the*armamentarium*of*
therapeutics*for*Crohn’s*disease*
! It!is!likely!that!cellYbased!therapies!will!have!a!role!in!the!treatment!of!CD!in!the!future.!!At!the!time!of!writing,!multiple!cell!products!are!in!development!for!the!treatment!of!CD,!including!autologous!HSCT!(ASTIC!study,!ClinicalTrials.gov!identifier:!NCT00297193;!Hawkey!and!Trialists,!2014),!allogeneic!bone!marrowYderived!mesenchymal!stem!cells!(MSC)!(“Prochymal”,!Mesoblast/Osiris;!ClinicalTrials.gov!identifier:!NCT00482092),!allogeneic!adipose!tissueYderived!MSC!(“Cx601”,!TiGenix;!ClinicalTrials.gov!identifier:!NCT01541579)!and!ovalbuminYspecific!ILY10+!CD4+!lymphocytes!(Desreumaux!et!al.,!2012).!!!
! Barriers!currently!exist!to!the!widespread!clinical!acceptance!of!cellYbased!therapy!for!CD.!!In!order!for!cell!therapy!to!become!a!clinically!acceptable!alternative!to!currently!available!pharmaceutical!therapies,!clinical!trials!will!have!to!robustly!demonstrate!efficacy!and!allow!the!calculation!of!estimates!of!effect!
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size!in!comparison!with!“gold!standard”!treatments,!such!as!biologics.!!Identification!of!the!mechanism!of!action!of!cell!therapies!in!humans!will!add!to!their!biological!plausibility!amongst!clinicians,!and!perhaps!allow!patient!stratification!by!focusing!therapy!on!patient!groups!that!are!most!likely!to!respond.!!!
! Financial!barriers!also!exist!to!the!development!of!cell!therapy,!including!high!costs!for!entry!into!this!market!and!high!costs!for!the!development!and!production!of!cell!therapy!products.!!For!example,!the!establishment!of!a!GMP!facility!at!Guy’s!Tower!required!a!capital!investment!of!over!£10M.!!The!hidden!costs!of!this!facility!include!the!capital!investment!required!to!establish!coYlocated!support!facilities,!including!a!flow!cytometry!core!and!a!clinical!research!facility.!!Furthermore,!development!of!the!underpinning!science!and!subsequent!development!of!the!cell!therapy!is!timeYconsuming!and!expensive.!!These!factors!will!limit!participation!in!cell!therapy!development!and!manufacture!to!a!small!number!of!academic!centres!and!early!phase!pharmaceutical!or!device!manufacturing!companies.!!The!high!cost!of!entry!and!subsequent!development!has!driven!extensive!collaboration!between!academic!centres!and!industry!in!the!development!of!cell!therapy!products.!!For!example,!the!“ONE!study”!consortium!is!a!transYAtlantic!collaboration!between!8!academic!centres!and!5!companies,!that!aims!to!define!the!optimum!cell!therapy!products!to!minimise!maintenance!immunosuppression!following!solid!organ!transplantation.!!MultiYcentre!collaborations!are!also!likely!to!be!required!in!order!to!recruit!patients!in!sufficient!numbers!to!conduct!clinical!trials!of!cell!therapy!in!the!future.!
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! The!immaturity!of!the!cell!therapy!market!represents!another!barrier!to!the!development!of!cellular!therapeutics.!!Cell!therapies!for!CD!are!currently!novel,!and!a!clinical!role!for!cell!therapy!has!not!yet!been!fully!defined.!!Cell!therapy!production!has!also!not!yet!achieved!economies!of!scale.!!Consequently,!the!business!model!for!cell!therapy!in!IBD!is!evolving.!!These!uncertainties!have!meant!that!the!infrastructure!for!cell!therapy!manufacture!and!the!onYgoing!cost!of!development!has!been!heavily!supported!by!public!funding.!!The!UK!Government!has!responded!to!this!need!by!establishing!the!Cell!Therapy!Catapult,!located!at!Guy’s!Tower.!!The!Cell!Therapy!Catapult!aims!to!support!and!develop!the!UK!cell!therapy!industry!by!providing!clinical,!technical!and!regulatory!expertise,!in!addition!to!developing!business!plans!and!pricing!in!the!development!of!cell!therapy!products.!!This!will!have!the!effect!of!reducing!the!risks!of!participating!in!this!sector.!
! The!proposed!clinical!trial!outlined!in!Section!12.9!(page!268)!has!the!potential!to!establish!the!safety!of!autologous!in#vitro!expanded!Tregs!in!CD.!!Were!this!trial!to!be!successful,!subsequent!phase!II!and!phase!III!clinical!trials!may!provide!evidence!of!clinical!effectiveness.!!Infliximab!therapy!for!CD!was!first!used!with!a!“bottom!up”!approach!in!patients!with!moderateYtoYsevere!disease,!who!had!failed!other!therapies!(Targan!et!al.,!1997).!!It!took!a!further!10!years!for!good!evidence!for!the!success!of!a!“topYdown”!approach!to!therapy!to!become!available!and!widely!accepted!(Colombel!et!al.,!2010;!D'Haens!et!al.,!2008).!!It!is!reasonable!to!assume!that!clinical!indications!for!in#vitro!expanded!Tregs!will!follow!the!same!paradigm.!!!
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! At!present,!the!projected!cost!of!manufacturing!an!autologous!in#vitro!expanded!Treg!cell!product!is!£16,500.!!This!is!comparable!with!the!cost!of!a!1Yyear!supply!of!infliximab!for!the!induction!and!maintenance!of!remission!in!CD:!!£16,800!for!an!80!kg!individual.!!It!is!reasonable!to!anticipate!that!the!cost!of!cell!therapy!manufacture!will!fall!as!the!technology!matures!and!economies!of!scale!arise.!!
12.11 Conclusions*
! In!conclusion,!these!data!suggest!that!the!Treg!population!that!can!be!expanded!in#vitro!from!CD4+CD25hiCD127loCD45RA+!CD!PB!precursors!is!likely!to!be!an!appropriate!population!for!further!development!as!a!potential!autologous!Treg!cell!therapy!for!CD.!!This!conclusion!is!based!on!observations!presented!in!this!thesis!that!this!in#vitro!expanded!Treg!population!exhibits!phenotypic!stability!and!stable!FOXP3!expression!following!in#vitro!expansion,!is!resistant!to!the!induction!of!a!proYinflammatory!phenotype,!homes!to!human!small!bowel!in#vivo!in!a!novel!preYclinical!model,!and!suppresses!proliferation!of!responder!T!cells!isolated!from!inflamed!CD!LP!and!MLN.!!!
! These!observations!suggest!that!the!conclusions!of!earlier!studies!on!both!freshly!isolated!CD4+CD25hiCD127loCD45RA+!Tregs!from!healthy!donors!(Miyara!et!al.,!2009)!and!Tregs!expanded!in#vitro#from!CD4+CD25hiCD127loCD45RA+!precursors!obtained!from!healthy!donors!(Baron!et!al.,!2007;!Hoffmann!et!al.,!2006;!2009)!can!be!extended!to!the!equivalent!Treg!populations!obtained!from!CD!patients.!!Consequently,!it!is!likely!that!the!general!conclusions!of!Treg!literature!derived!from!healthy!control!samples!can!be!applied!to!CD!Tregs.!!This!suggests!that!it!may!
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not!be!necessary!to!recapitulate!experimental!data!originally!derived!from!healthy!control!Tregs!using!CD!patient!samples,!unless!the!results!are!required!for!the!development!of!novel!therapeutics!and!a!subsequent!licensing!application,!or!to!address!a!specific!safety!issue!related!to!future!CD!therapeutics.!!
! The!7Yhour!assay!of!Treg!in#vitro#suppressive!function!was!originally!validated!in!comparison!with!a!96Yhour!proliferation!assay!for!in#vitro#expanded!Tregs!with!the!intention!of!providing!a!novel!technique!to!rapidly!assess!the!function!of!in#vitro#expanded!Treg!lots.!!This!might!ultimately!be!a!complementary!approach!to!the!assessment!of!FOXP3#TSDR!demethylation!in!in#vitro#expanded!Treg!lots.!!It!may!be!useful!to!include!these!assays!for!information!in!forthcoming!clinical!trials!of!Treg!cell!therapy,!as!correlation!between!the!results!of!these!assays!!and!in#vivo#biological!activity!may!provide!insights!into!the!biology!of!adoptively!transferred!in#vitro#expanded!Tregs!in!humans.!!As!additional!data!become!available,!a!role!for!these!assays!in!the!assessment!of!in#vitro!expanded!Treg!lots!prior!to!infusion!to!humans!may!become!apparent.!!
! Future!work!will!focus!on!the!development!of!humanised!models!of!IBD,!which!will!provide!platforms!for!preYclinical!testing!of!in#vitro#expanded!Tregs,!in!addition!to!other!novel!therapeutics.!!Funding!is!currently!being!sought!to!convert!the!isolation!and!expansion!of!PB!CD4+CD25hiCD127loCD45RA+!Tregs!to!a!fully!GMP!process.!!A!phase!I!clinical!trial!of!this!cell!product!will!then!be!initiated.!!These!data!pave!the!way!for!further!development!of!Tregs!expanded!in#vitro#from!CD4+CD25hiCD127loCD45RA+!CD!PB!precursors!as!a!cellYbased!therapy!for!CD.!
! !
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